Earth Science Tech Inc. (ETST) Seeks Dual Listing; Boasts Increased Product Lines, Distribution
- Pursuing dual listing of common shares on the Canadian Securities Exchange
- Engaged a full-service law firm and consultant to manage compliance
- Lots of opportunity in 2019 with increased product lines, increased distribution and new partnerships
Earth Science Tech Inc. (OTCQB: ETST), an innovative biotech company based in Florida, is actively pursuing a dual listing of its common shares on the Canadian Securities Exchange (“CSE”). In December 2018, ETST engaged the counsel of Fasken, a full-service law firm with offices in Canada and worldwide, to assist with the process, including preparing and filing the required documentation (http://nnw.fm/vk7aI).
In addition, ETST has engaged consultant Derek Lindsay to manage compliance while the company moves toward dual listing (http://nnw.fm/a3vQc). Along with managing compliance, Lindsay will be tasked with implementing an investor relations program and improving communications with investors.
“Dual listing is a major achievement and one that can provide ETST access to new investors and capital,” Lindsay, who has solid experience in accelerating the growth of both private and public companies, stated in a news release. Lindsay has served in various capacities and is well-versed in capital raising, strategic advising, investor relations and risk management.
Actively working toward dual listing is not halting the company’s continued work in the CBD, nutraceutical and pharmaceutical fields; nor is it slowing its advancement of medical devices or research and development activities. Preparations are in place for the launch of three new CBD products. The first commercial batch of Hygee medical devices is nearing completion and will be launched in Vietnam, which will act as a proving ground for the introduction of the device into other countries (http://nnw.fm/K9UhP).
Already distributing products to 40 countries, ETST recently expanded its sales reach into Mexico and South America through a distribution partnership agreement with Forzagen (http://nnw.fm/fZh3m). In addition to global distribution expansion, the company is increasing its markets in the United States. Thanks to a recent agreement with CannaBiz and Desert Sun Distribution, ETST’s CBD product line will soon be available to chiropractors, dispensaries, pharmacies, health care practitioners, athletic clubs and clinics.
In a news release (http://nnw.fm/a1Mfk), ETST Chairman Nickolas S. Tabraue said, “We have a lot of opportunity on deck for 2019, and we look forward to sharing the results of our strategies, which include our Latin American distribution partnership and upcoming High Grade Full Spectrum Iq2 Cannabinoids shot.”
For more information, visit the company’s website at www.EarthScienceTech.com
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
- Pursuing dual listing of common shares on the Canadian Securities Exchange
- Engaged a full-service law firm and consultant to manage compliance
- Lots of opportunity in 2019 with increased product lines, increased distribution and new partnerships
Earth Science Tech Inc. (OTCQB: ETST), an innovative biotech company based in Florida, is actively pursuing a dual listing of its common shares on the Canadian Securities Exchange (“CSE”). In December 2018, ETST engaged the counsel of Fasken, a full-service law firm with offices in Canada and worldwide, to assist with the process, including preparing and filing the required documentation (http://nnw.fm/vk7aI).
In addition, ETST has engaged consultant Derek Lindsay to manage compliance while the company moves toward dual listing (http://nnw.fm/a3vQc). Along with managing compliance, Lindsay will be tasked with implementing an investor relations program and improving communications with investors.
“Dual listing is a major achievement and one that can provide ETST access to new investors and capital,” Lindsay, who has solid experience in accelerating the growth of both private and public companies, stated in a news release. Lindsay has served in various capacities and is well-versed in capital raising, strategic advising, investor relations and risk management.
Actively working toward dual listing is not halting the company’s continued work in the CBD, nutraceutical and pharmaceutical fields; nor is it slowing its advancement of medical devices or research and development activities. Preparations are in place for the launch of three new CBD products. The first commercial batch of Hygee medical devices is nearing completion and will be launched in Vietnam, which will act as a proving ground for the introduction of the device into other countries (http://nnw.fm/K9UhP).
Already distributing products to 40 countries, ETST recently expanded its sales reach into Mexico and South America through a distribution partnership agreement with Forzagen (http://nnw.fm/fZh3m). In addition to global distribution expansion, the company is increasing its markets in the United States. Thanks to a recent agreement with CannaBiz and Desert Sun Distribution, ETST’s CBD product line will soon be available to chiropractors, dispensaries, pharmacies, health care practitioners, athletic clubs and clinics.
In a news release (http://nnw.fm/a1Mfk), ETST Chairman Nickolas S. Tabraue said, “We have a lot of opportunity on deck for 2019, and we look forward to sharing the results of our strategies, which include our Latin American distribution partnership and upcoming High Grade Full Spectrum Iq2 Cannabinoids shot.”
For more information, visit the company’s website at www.EarthScienceTech.com
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
